Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci

被引:38
|
作者
Chun, Sejong [1 ]
Huh, Hee Jae [1 ]
Lee, Nam Yong [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul 135710, South Korea
关键词
Viridans streptococci; Penicillin; Resistance; Microbial; IN-VITRO ACTIVITIES; PENICILLIN-RESISTANT; HEMOLYTIC STREPTOCOCCI; NEUTROPENIC PATIENTS; PNEUMONIAE; IDENTIFICATION; ANTIBIOTICS; INFECTIONS; BACTEREMIA; CHILDREN;
D O I
10.3343/alm.2015.35.2.205
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Viridans group streptococci (VGS) are both commensal microbes and potential pathogens. Increasing resistance to penicillin in VGS is an ongoing issue in the clinical environment. We investigated the difference in susceptibility and resistance to penicillin among various VGS species. Methods: In total 1,448 VGS isolated from various clinical specimens were analyzed over a two-yr period. Identification and antimicrobial susceptibility test was performed by the automated VITEK 2 system (bioMerieux, France) or the Micro Scan MICroSTREP system (Siemens, Germany). Results: Among the 1,448 isolates, 412 were isolated from blood (28.4%). Streptococcus mitis group was the most frequently isolated (589 isolates, 40.7%), followed by the Streptococcus anginosus group (290 isolates, 20.0%), Streptococcus sanguinis group (179 isolates, 12.4%) and Streptococcus salivarius group (57 isolates, 3.9%). In total, 314 isolates could not be identified up to the species level. The overall non-susceptibility to penicillin was observed to be 40.0% (resistant, 11.2% and intermediately resistant, 28.8%) with uneven distribution among groups; 40.2% in Streptococcus sanguinis group (resistant, 5.0% and intermediately resistant, 35.2%), 60.3% in Streptococcus mitis group (resistant, 20.9% and intermediately resistant, 39.4%), 78.9% in Streptococcus salivarius group (resistant, 8.8% and intermediately resistant, 70.1%), and 6.2% in Streptococcus anginosus group (resistant, 1.7% and intermediately resistant, 4.5%). Conclusions: Antimicrobial resistance patterns towards penicillin show differences among various VGS; this should be considered while devising an effective antimicrobial treatment against VGS.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [11] Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis
    Quintero, Ana M.
    Vidal, Diego A. Cruz
    Klamer, Brett G.
    Ardura, Monica, I
    Oyeniran, Sophonie J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (07) : 381 - 391
  • [12] Penicillin Susceptibility of Viridans Group Streptococci Isolated from the Oropharynx of Patients with Hematological Malignancy
    Sayin-Kutlu, Selda
    Okke, Demet
    Demir, Melek
    Tepeli, Ebru
    Sari, Ismail
    KLIMIK JOURNAL, 2012, 25 (01) : 6 - 9
  • [13] Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases
    Ergin, Alper
    Eser, Ozgen Koseoglu
    Hascelik, Gulsen
    NEW MICROBIOLOGICA, 2011, 34 (02) : 187 - 193
  • [14] Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility
    Shargian, Liat
    Paul, Mical
    Nachshon, Tal
    Ayada, Gida
    Nesher, Lior
    Raanani, Pia
    Ben-Zvi, Haim
    Henig, Oryan
    Yahav, Dafna
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (02) : 177 - 182
  • [15] Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
    Lackner, Michaela
    de Hoog, G. Sybren
    Verweij, Paul E.
    Najafzadeh, Mohammad J.
    Curfs-Breuker, Ilse
    Klaassen, Corne H.
    Meis, Jacques F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2635 - 2642
  • [16] Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients
    Sahasrabhojane, Pranoti
    Galloway-Pena, Jessica
    Velazquez, Luis
    Saldana, Miguel
    Horstmann, Nicola
    Tarrand, Jeffrey
    Shelburne, Samuel A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (06) : 558 - 562
  • [17] Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy
    Sheehy, Joshua
    Scott, Ashleigh P.
    Henden, Andrea S.
    Kennedy, Glen
    Redmond, Andrew M.
    Stewart, Adam G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2040 - 2047
  • [18] Interaction of Apidaecin Ib with Phospholipid Bilayers and its Edwardsiella Species-specific Antimicrobial Activity
    Seo, Jung-Kil
    Go, Hye-Jin
    Moon, Ho Sung
    Lee, Min Jeong
    Hong, Yong-Ki
    Do Jeong, Hyun
    Nam, Bo-Hye
    Park, Tae Hyun
    Park, Nam Gyu
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (01): : 115 - 122
  • [19] A New Species-Specific Typing Method for Salivarius Group Streptococci Based on the Dephospho-Coenzyme A Kinase (coaE) Gene Sequencing
    Abdelbary, Mohamed M. H.
    Wilms, Gerrit
    Conrads, Georg
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [20] Antimicrobial susceptibility pattern of beta-haemolytic group A, C and G streptococci isolated from North India
    Dhanda, Vanita
    Chaudhary, Priyanka
    Toor, Devinder
    Kumar, Rajesh
    Chakraborti, Anuradha
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 386 - 393